Diagnostic Utility of Osteocalcin, Undercarboxylated Osteocalcin, and Alkaline Phosphatase for Osteoporosis in Premenopausal and Postmenopausal Women
2
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background: We aimed to investigate the diagnostic utility of osteocalcin (OC), undercarboxylated osteocalcin (ucOC), and alkaline phosphatase (ALP) in pre- and postmenopausal women for femoral neck, L1-4, and L2-4 bone mineral density (BMD) values by taking into consideration their age, body mass index (BMI), and menopausal status. Methods: Premenopausal (N=40) and postmenopausal cases (N=42) were classified as 25-34 or 35-45 yr of age and within the first 5 yr or 5 yr or more after the onset of menopause, respectively. Results: Among the groups, statistical differences were found for age, BMI, OC, ucOC, ALP, femoral neck BMD, L1-4 BMD, and L2-4 BMD. The highest serum OC, ucOC, and ALP levels were observed in cases within the first 5 yr after the onset of menopause, probably due to a more rapid bone turnover rate. The best predictors for the femoral neck osteoporosis were ALP, OC, and calcium (areas under the ROC curve [AUC]=0.882, 0.829, and 0.761, respectively), and those for L1-4 and L2-4 osteoporosis were OC, ALP, and ucOC (AUC=0.949, 0.873, and 0.845; and 0.866, 0.819, and 0.814, respectively). Multiple logistic regression analysis revealed that the most discriminative parameter for osteoporosis was OC. Conclusions: These results indicate that serum OC levels, with or without ucOC and ALP, may be useful to monitor follow-up changes that currently cannot be assessed with BMD and to diagnose femoral neck, L1-4 spine, and L2-4 spine osteoporosis.
Abstract
Background: We aimed to investigate the diagnostic utility of osteocalcin (OC), undercarboxylated osteocalcin (ucOC), and alkaline phosphatase (ALP) in pre- and postmenopausal women for femoral neck, L1-4, and L2-4 bone mineral density (BMD) values by taking into consideration their age, body mass index (BMI), and menopausal status. Methods: Premenopausal (N=40) and postmenopausal cases (N=42) were classified as 25-34 or 35-45 yr of age and within the first 5 yr or 5 yr or more after the onset of menopause, respectively. Results: Among the groups, statistical differences were found for age, BMI, OC, ucOC, ALP, femoral neck BMD, L1-4 BMD, and L2-4 BMD. The highest serum OC, ucOC, and ALP levels were observed in cases within the first 5 yr after the onset of menopause, probably due to a more rapid bone turnover rate. The best predictors for the femoral neck osteoporosis were ALP, OC, and calcium (areas under the ROC curve [AUC]=0.882, 0.829, and 0.761, respectively), and those for L1-4 and L2-4 osteoporosis were OC, ALP, and ucOC (AUC=0.949, 0.873, and 0.845; and 0.866, 0.819, and 0.814, respectively). Multiple logistic regression analysis revealed that the most discriminative parameter for osteoporosis was OC. Conclusions: These results indicate that serum OC levels, with or without ucOC and ALP, may be useful to monitor follow-up changes that currently cannot be assessed with BMD and to diagnose femoral neck, L1-4 spine, and L2-4 spine osteoporosis.
참고문헌 (22)
- "NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy", South Med J, 94, pp.569~573 (2001)
- Garnero P, "Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis", J Bone Miner Res, 3, pp.337~349 (1996)
- Christiansen C, "Estrogens, bone loss and preservation", Osteoporos Int, 1, pp.7~13 (1990)
- Dalle Carbonare L, "Bone microarchitecture as an important determinant of bone strength", J Endocrinol Invest, 27, pp.99~105 (2004)
- Kanis JA., "Diagnosis of osteoporosis and assessment of fracture risk", Lancet, 359, pp.1929~1936 (2002)
- Sinaki M., "Prevention and treatment of osteoporosis, In Physical medicine and rehabilitation, 3rd ed", pp.929~949 (2006), Elsevier
- Garnero P, "Biochemical markers of bone turnover. Applications for osteoporosis", Endocrinol Metab Clin North Am, 27, pp.303~323 (1998)
- Allison JL, "Measurement of osteocalcin", Ann Clin Biochem, 37, pp.432~446 (2000)
- Swaminathan R, "Biochemical markers of bone turnover", Clin Chim Acta, 313, pp.95~105 (2001)
- Aonuma H, "Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption", Tohoku J Exp Med, 218, pp.201~205 (2009)
- Vergnaud P, "Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in eldery women: the EPIDOS study", J Clin Endocrinol Metab, 82, pp.719~724 (1997)
- Booth SL, "Vitamin K intake and bone mineral density in women and men", Am J Clin Nutr, 77, pp.512~516 (2003)
- Report of a WHO study group, "Assessment of fracture risk and its application to screening for postmenopausal osteoporosis", World Health Organ Tech Rep Ser, 943, pp.1~129 (1994)
- Sokoll LJ, "Undercarboxylated osteocalcin and development of a method to determine vitamin K status", Clin Chem, 41, pp.1121~1128 (1995)
- Chailurkit LO, "Ongphiphadhanakul B, Piaseu N, Saetung S, Rajatanavin R. Biochemical markers of bone turnover and response of bone mineral density to intervention in early postmenopausal women: an experience in a clinical laboratory", Clin Chem, 47, pp.1083~1088 (2001)
- Ivaska KK, "Release of intact and fragmented osteocalcin molecules from bone matrix during bone resorption in vitro", J Biol Chem, 279, pp.18361~18369 (2004)
- Lindsay R, "The menopause and osteoporosis", Obstet Gynecol, 87(S2), pp.S16~S19 (1996)
- Gnudi S, "Evaluation of the relative rates of bone mineral content loss in postmenopause due to both estrogen deficiency and ageing", Boll Soc Ital Biol Sper, 66, pp.1153~1159 (1990)
- Plantalech L, "Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women", J Bone Miner Res, 6, pp.1211~1216 (1991)
- Szulc P, "Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women", J Clin Invest, 91, pp.1769~1774 (1993)
- Knapen MH, "Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 yr after menopause", Calcif Tissue Int, 63, pp.375~379 (1998)
- Yasui T, "Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women", J Endocrinol Invest, 29, pp.913~918 (2006)